Arterial stiffness is related to systemic inflammation in essential hypertension

Azra Mahmud1, John Feely

  • 1Department of Therapeutics, Hypertension Clinic, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland.

Insights

High-sensitivity C-reactive protein, a marker of inflammation, is independently linked to arterial stiffness in patients with essential hypertension. This finding highlights the role of systemic inflammation in cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Hypertension Studies

Background:

  • High-sensitivity C-reactive protein (hs-CRP) indicates vascular inflammation and is an atherosclerotic risk factor.
  • Arterial stiffness is linked to hs-CRP in healthy individuals and those with systemic vasculitis.
  • Essential hypertension is associated with increased cardiovascular risk, potentially influenced by inflammatory markers.

Purpose of the Study:

  • To investigate the relationship between inflammatory markers (IL-6, TNF-alpha, hs-CRP) and arterial stiffness in untreated essential hypertension patients.
  • To determine if hs-CRP is an independent predictor of arterial stiffness markers in this population.

Main Methods:

  • Noninvasive assessment of augmentation index and pulse wave velocity in 78 untreated essential hypertension patients.
  • Measurement of plasma levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and high-sensitivity C-reactive protein (hs-CRP) using ELISA.
  • Statistical analysis including correlation and multiple stepwise regression.

Main Results:

  • Pulse wave velocity showed significant correlations with hs-CRP (r=0.31), TNF-alpha (r=0.30), and IL-6 (r=0.21).
  • Heart rate-corrected augmentation index correlated with hs-CRP (r=0.37) and IL-6 (r=0.24).
  • hs-CRP emerged as an independent predictor of both pulse wave velocity and augmentation index.

Conclusions:

  • Systemic inflammation, as indicated by hs-CRP, is independently associated with aortic stiffness (pulse wave velocity) and wave reflection (augmentation index) in essential hypertension.
  • hs-CRP is a significant marker linking inflammation to arterial stiffness in hypertensive individuals.
  • These findings underscore the importance of managing inflammation in hypertension to mitigate cardiovascular risk.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...